Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Status:
Completed
Trial end date:
2008-07-10
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled study evaluating the effects of rosiglitazone on functional
brain activity and cognition in patients with mild to moderate Alzheimer's Disease (AD).